< The University of Manchester Site
UMIC – University of Manchester Incubator Company
topborder
About UMIC
Manchester Technology Quarter (MTQ)





IDEA EVALUATION PORTAL
Manchester Bioscience Incubator (MBI)
Core Technology Facility (CTF)
North Campus Incubator
One Central Park
Broadstone Knowledge Mill
Biotech Business Support
High Tech Business Support
Events
Jobs
Links
Contact Us
Intranet
video


Valid CSS!


HOME
ABOUT UMIC
INCUBATOR COMPANIES
PARTNERS&ASSOCIATES;
CONFERENCING
BIOTECH BUSINESS UNIT
HI TECH BUSINESS UNIT
E-NEWSLETTER
About UMICBusiness ModelPortfolio of AccommodationKey ContactsThe Manchester ConnectionManchester Technology Quarter (MTQ)Manchester Momentum


Manchester Technology Quarter (MTQ)

MTQ is a concept developed to describe the exciting blend of research, Incubation and commercial activity that exists in a very important quadrant within the University of Manchester campus.

In particular, the Manchester Bioscience Incubator and the Core Technology Facility sit at the heart of an exciting cluster that generates ideas and intellectual property. The University of Manchester’s Faculties of Life Sciences, Medical and Humans Sciences and Engineering & Physical Sciences together with the IP commercialisation company for these Faculties, UMIP Limited, are all proximally located in the Quarter. Also, within close proximity is the Central Manchester Health Trust, with its array of clinics and research centres in Medicine, the innovation management team of Trustech and the Northwest Genetics Knowledge Park.

This has created an exciting Biotechnology and Hi-Tech cluster right in the heart of the University of Manchester campus and there is no doubt that the Manchester Bioscience Incubator and the Core Technology Facility play an important role in harnessing these activities.

In addition to the Bioscience-based activities, there are significant Hi-Tech research activities that are complementary and relevant to the Manchester Technology Quarter. These include a world class Materials Science Centre. The School is the largest single Materials focus in any European University. In addition, the Organic Materials Centre (OMIC) also has a commercial focus and interests in assisting SME’s. OMIC is a UK government supported University Innovation Centre for the speciality organic materials and polymer industries, and is bridging the gap between the knowledge which UK Universities generate and that which businesses need in order to innovate and grow.

Furthermore, the School of Chemistry (from which Nanoco Technologies Ltd. spun out) has a growing reputation for work at the academic–commercial interface. The Manchester Technology Quarter has recently had two new facilities enter into the network; the MIB (Manchester Interdisciplinary Centre) and the Photonics Institute. The MIB is a new type of university Research Institute that has been designed to enable our academic community to explore specific areas of interdisciplinary quantitative bioscience at the highest level, largely through the efforts of multidisciplinary research teams.

The newly opened Photonics Institute will also play a key role in the interface between Bioscience and Hi-Tech.

The Manchester Technology Quarter is growing rapidly and is making a significant contribution to both the University of Manchester’s drive towards academic research excellence, and also to the commercial SME clusters that are ideally positioned in both the Bioscience Incubator and the Core Technology Facility, to engage with this highly reputable Centre of Excellence.

 

empty

empty

Unsubscribe

Current News

Nano-Structured Materials in Tissue Engineering Focus Group Meeting

divider

New Business Support Scheme for Tenants

divider

£4m Innovation Vouchers Scheme launched

divider

31st BioNow Network Evening.

divider

Epistem to Present Plucked Hair Biomarker Data at ASCO-NCI-EORTC Meeting

divider

Arvia makes a splash

divider

BVCA Spin-Out Event 2008: Transformational growth in spin-out companies

divider

OFFICIAL OPENING OF STOCKPORT BUSINESS INCUBATOR

divider

Fire tornado to launch science festival programme – MOSI

divider

HOULDSWORTH KNOWLEDGE VILLAGE WINS TOP REGENERATION AWARD

divider

Epistem to present minimally invasive oncology biomarker data at AACR Meeting

divider

Manchester SME up against the big corporations

divider

Scientists in Schools

divider

Success for Houldsworth Knowledge Village

divider

Bionow R & D Tax Credits Event – Manchester & Liverpool Venues

divider

NWIN Biotech and Healthcare Networking Event

divider

EPISTEM AND ROTTAPHARM ANNOUNCE POSITIVE RESULTS

divider

Risk Awareness workshop – 18th Sept

divider

Regional Sector Networking Event: Biotech / Healthcare

divider

Welcome to UMIC\’s 2nd e-newsletter!

divider

Northwest business software provider launch online business TV channel

divider

F2G Ltd completes £6.3million financing round to fund preclinical and clinical development

divider

Bionow Network Evening – Tuesday 16 September 2008

divider

Knowledge village scheme on awards shortlist

divider

DxS Announces Appointment of Ron Long as Non-Executive Director

divider

Faculty of Engineering – N8 Centre for Translational Regenerative Medicine: Commercial Director (0.4 fte) wanted.

divider

The University of Manchester and GSK strike new research alliance

divider

Manchester gains funding for €170m Biobank.

divider

Darling meets spin-outs during Manchester visit

divider

Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests

divider

Manchester scientists highlighted for contribution to UK economy

divider

DxS Announces Plans to Expand its Manufacturing Capacity and Award of ISO 13485 certification

divider

TARGETED MOLECULAR DIAGNOSTICS and DxS ANNOUNCE A TIMELY WORKSHOP ON ASSESSING SOLID TUMOR MUTATIONS

divider

Welcome to UMIC’s first enewsletter!

divider

Stem cell hope for paralysed

divider

UMIC launches commercial drug discovery service for UK life sciences

divider

Mobysoft – SMS for Excellence

divider

Scientific workshop sets up at Broadstone Mill

divider

Illuminating Research – A bright future ahead as Nanoco sign a distribution agreement with Sigma-Aldrich

divider

DxS and Epigenomics AG enter Into Strategic Cross-Licensing Agreement for the Use of Scorpions® Technology

divider

Nanoco Technologies present a flagship example of the UK’s ability to transform world-class research into cutting edge business

divider

UMIP Spin-Out Gives Hope to Cancer Patients

divider

empty
Login to UMIC
 
   
Author
Author